These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 20949542)

  • 1. Glycosylation influences on the aggregation propensity of therapeutic monoclonal antibodies.
    Kayser V; Chennamsetty N; Voynov V; Forrer K; Helk B; Trout BL
    Biotechnol J; 2011 Jan; 6(1):38-44. PubMed ID: 20949542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of pH, temperature, and salt on the stability of Escherichia coli- and Chinese hamster ovary cell-derived IgG1 Fc.
    Li CH; Narhi LO; Wen J; Dimitrova M; Wen ZQ; Li J; Pollastrini J; Nguyen X; Tsuruda T; Jiang Y
    Biochemistry; 2012 Dec; 51(50):10056-65. PubMed ID: 23078371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure/activity studies of the anti-MUC1 monoclonal antibody C595 and synthetic MUC1 mucin-core-related peptides and glycopeptides.
    Spencer DI; Missailidis S; Denton G; Murray A; Brady K; Matteis CI; Searle MS; Tendler SJ; Price MR
    Biospectroscopy; 1999; 5(2):79-91. PubMed ID: 10217327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and characterization of IgG1 with asymmetrical Fc glycosylation.
    Ha S; Ou Y; Vlasak J; Li Y; Wang S; Vo K; Du Y; Mach A; Fang Y; Zhang N
    Glycobiology; 2011 Aug; 21(8):1087-96. PubMed ID: 21470983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of domain deletion, glycosylation, and long IgG3 hinge on the biodistribution and serum stability properties of a humanized IgG1 immunoglobulin, hLL2, and its fragments.
    Leung SO; Qu Z; Hansen HJ; Shih LB; Wang J; Losman MJ; Goldenberg DM; Sharkey RM
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3106s-3117s. PubMed ID: 10541351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic antibodies and related products: choosing the right structure for success].
    Beck A; Wagner-Rousset E; Wurch T; Corvaia N
    Med Sci (Paris); 2009 Dec; 25(12):1024-32. PubMed ID: 20035674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of IgG LC:HC ratio in stably transfected CHO cells and study of the impact on expression, aggregation, glycosylation and conformational stability.
    Ho SC; Koh EY; van Beers M; Mueller M; Wan C; Teo G; Song Z; Tong YW; Bardor M; Yang Y
    J Biotechnol; 2013 Jun; 165(3-4):157-66. PubMed ID: 23583871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acid-induced aggregation of human monoclonal IgG1 and IgG2: molecular mechanism and the effect of solution composition.
    Hari SB; Lau H; Razinkov VI; Chen S; Latypov RF
    Biochemistry; 2010 Nov; 49(43):9328-38. PubMed ID: 20843079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation and comparative characterization of glycosylated and aglycosylated human IgG1 antibodies.
    Hristodorov D; Fischer R; Joerissen H; Müller-Tiemann B; Apeler H; Linden L
    Mol Biotechnol; 2013 Mar; 53(3):326-35. PubMed ID: 22427250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of humanized IgGs in glycoengineered Pichia pastoris.
    Li H; Sethuraman N; Stadheim TA; Zha D; Prinz B; Ballew N; Bobrowicz P; Choi BK; Cook WJ; Cukan M; Houston-Cummings NR; Davidson R; Gong B; Hamilton SR; Hoopes JP; Jiang Y; Kim N; Mansfield R; Nett JH; Rios S; Strawbridge R; Wildt S; Gerngross TU
    Nat Biotechnol; 2006 Feb; 24(2):210-5. PubMed ID: 16429149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aglycosylated antibodies and the methods of making and using them: WO2008030564.
    Jefferis R
    Expert Opin Ther Pat; 2009 Jan; 19(1):101-5. PubMed ID: 19441902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A thermal-cycling method for disaggregating monoclonal antibody oligomers.
    Sadavarte RH; Ghosh R
    J Pharm Sci; 2014 Mar; 103(3):870-8. PubMed ID: 24549731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of deglycosylation and thermal stress on conformational stability of a full length murine IgG2a monoclonal antibody: observations from molecular dynamics simulations.
    Wang X; Kumar S; Buck PM; Singh SK
    Proteins; 2013 Mar; 81(3):443-60. PubMed ID: 23065923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of constant and variable domain glycosylation on pharmacokinetics of therapeutic antibodies in mice.
    Millward TA; Heitzmann M; Bill K; Längle U; Schumacher P; Forrer K
    Biologicals; 2008 Jan; 36(1):41-7. PubMed ID: 17890101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular analysis of IgM rheumatoid factor binding to chimeric IgG.
    Artandi SE; Canfield SM; Tao MH; Calame KL; Morrison SL; Bonagura VR
    J Immunol; 1991 Jan; 146(2):603-10. PubMed ID: 1702808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salt-induced aggregation of a monoclonal human immunoglobulin G1.
    Rubin J; Linden L; Coco WM; Bommarius AS; Behrens SH
    J Pharm Sci; 2013 Feb; 102(2):377-86. PubMed ID: 23147563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aglycosylated full-length IgG antibodies: steps toward next-generation immunotherapeutics.
    Ju MS; Jung ST
    Curr Opin Biotechnol; 2014 Dec; 30():128-39. PubMed ID: 25035939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of acid exposure on the conformation, stability, and aggregation of monoclonal antibodies.
    Ejima D; Tsumoto K; Fukada H; Yumioka R; Nagase K; Arakawa T; Philo JS
    Proteins; 2007 Mar; 66(4):954-62. PubMed ID: 17154421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving the solubility of anti-LINGO-1 monoclonal antibody Li33 by isotype switching and targeted mutagenesis.
    Pepinsky RB; Silvian L; Berkowitz SA; Farrington G; Lugovskoy A; Walus L; Eldredge J; Capili A; Mi S; Graff C; Garber E
    Protein Sci; 2010 May; 19(5):954-66. PubMed ID: 20198683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of freezing on pH of buffered solutions and consequences for monoclonal antibody aggregation.
    Kolhe P; Amend E; Singh SK
    Biotechnol Prog; 2010; 26(3):727-33. PubMed ID: 20039442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.